Virtus ETF Advisers LLC Morphic Holding, Inc. Transaction History

Virtus ETF Advisers LLC

$183 Million
Q1 2024

A detailed history of Virtus ETF Advisers LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,935 shares of MORF stock, worth $99,995. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,935

Previous 3,133 6.32%

Holding current value

$99,995

Previous $90,000 14.44%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $5,274 - $7,981	-198 Reduced 6.32%	2,935 $103,000
Q4 2023 Feb 15, 2024	BUY	$19.95 - $31.0 $29,506 - $45,849	1,479 Added 89.42%	3,133 $90,000
Q3 2023 Nov 07, 2023	SELL	$21.33 - $59.42 $3,498 - $9,744	-164 Reduced 9.02%	1,654 $37,000
Q2 2023 Aug 14, 2023	SELL	$34.33 - $62.11 $63,991 - $115,773	-1,864 Reduced 50.62%	1,818 $104,000
Q1 2023 May 15, 2023	SELL	$26.01 - $48.69 $36,856 - $68,993	-1,417 Reduced 27.79%	3,682 $138,000

Q4 2022 Feb 14, 2023	BUY	$24.14 - $30.37 $748 - $941	31 Added 0.61%	5,099 $136,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $911 - $1,368	41 Added 0.82%	5,068 $143,000
Q2 2022 Aug 12, 2022	BUY	$19.74 - $43.01 $30,281 - $65,977	1,534 Added 43.92%	5,027 $109,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $7,250 - $10,404	-200 Reduced 5.42%	3,493 $140,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $18,173 - $27,602	420 Added 12.83%	3,693 $175,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $9,060 - $11,407	-169 Reduced 4.91%	3,273 $185,000
Q2 2021 Aug 10, 2021	SELL	$45.13 - $64.99 $247,583 - $356,535	-5,486 Reduced 61.45%	3,442 $198,000
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $4,465 - $12,727	150 Added 1.71%	8,928 $565,000
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $225,243 - $303,279	8,778 New	8,778 $295,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Morphic Holding, Inc. Transaction History